<DOC>
	<DOCNO>NCT02564497</DOCNO>
	<brief_summary>The purpose study compare Pharmacokinetics ( PK ) Process E belatacept relative Process C belatacept Healthy subject</brief_summary>
	<brief_title>A Study Compare Pharmacokinetics Belatacept Using Active Pharmaceutical Ingredient Manufactured Process E Relative Process C</brief_title>
	<detailed_description />
	<mesh_term>Abatacept</mesh_term>
	<criteria>1 . Signed Informed Consent 2 . Target population : Healthy male female . 3 . Males female , age 18 55 year , inclusive . 4 . Women child bear potential ( WOCBP ) negative serum urine pregnancy test 5 . Women must breastfeed 6 . Men WOCBP must agree follow instruction contraception 1 . History TB , malignancy , chronic acute infecton disease . 2 . History acute chronic medical illness 3 . Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG clinical laboratory determination beyond consistent target population . 4 . History allergy belatacept relate compound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>